Screening and Quantitative Monitoring of Calreticulin (CALR) Type-2 Positive Patients with Myelofibrosis Following Allogeneic Stem Cell Transplantation using a novel Digital-PCR Assay

被引：0
|
作者：
Kroeger, N. [1 ]
Badbaran, A. [1 ]
Christopeit, M. [1 ]
Wolschke, C. [1 ]
Ayuk, F. [1 ]
Aranyossy, T. [1 ]
Fehse, B. [1 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Dept Stem Cell Transplantat, Hamburg, Germany
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O146
引用
收藏
页码：S85 / S86
页数：2
相关论文
共 50 条
  • [21] Monitoring measurable residual disease and chimerism in patients with JAK2 V617F-positive myelofibrosis after allogeneic hematopoietic cell transplantation
    Lee, Jong-Mi
    Ahn, Ari
    Min, Eun Jeong
    Lee, Sung-Eun
    Kim, Myungshin
    Kim, Yonggoo
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [22] Monitoring measurable residual disease and chimerism in patients with JAK2 V617F-positive myelofibrosis after allogeneic hematopoietic cell transplantation
    Jong-Mi Lee
    Ari Ahn
    Eun Jeong Min
    Sung-Eun Lee
    Myungshin Kim
    Yonggoo Kim
    Blood Cancer Journal, 13
  • [23] Monitoring JAK3 mRNA levels in patients with GVHD after allogeneic hematopoietic stem cell transplantation by real-time quantitative PCR.
    Li, Qihui
    Du, Xin
    Geng, Suxia
    Weng, Jianyu
    Guo, Rong
    Lu, Zesheng
    Xing, Haizhou
    BLOOD, 2006, 108 (11) : 410B - 410B
  • [24] Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of JAK2 V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation
    Langabeer, Stephen E.
    Nolan, James
    Haslam, Karl
    Clarke, Lindsey
    Flavin, Richard
    Conneally, Eibhlin
    CASE REPORTS IN HEMATOLOGY, 2015, 2015
  • [25] Outcomes for Myelofibrosis Patients Following Myeloablative Allogeneic Stem Cell Transplantation Using the Orca-T Graft from HLA-Matched Related and Unrelated Donors
    Arpita, Gandhi
    Moroz, Anna
    Muffly, Lori
    Shiraz, Parveen
    Schachter, Levanto
    Fernhoff, Nathaniel B.
    McClellan, J. Scott
    Negrin, Robert S.
    Gotlib, Jason
    Meyer, Everett H.
    BLOOD, 2021, 138 : 1819 - +
  • [26] The value of monitoring CML and ALL patients harboring the bCR-ABL translocation by serial real-time quantitative PCR after allogeneic stem cell transplantation
    Gärtner, F
    Rebelo, M
    Potthoff, K
    Zehbe, S
    Waller, C
    Bertz, H
    Finke, J
    BONE MARROW TRANSPLANTATION, 2002, 29 : S122 - S123
  • [27] Quantitative Monitoring By RT-PCR of Molecular Markers on Day+100 after Allogeneic Stem Cell Transplantation Predicts Outcome in Patients with Acute Myeloid Leukemia
    Hubmann, Max
    Zeber, Christina
    Pfirrmann, Markus
    Koehnke, Thomas
    Engel, Nicole
    Fritsch, Susanne
    Prevalsek, Dusan
    Schneider, Stephanie
    Dufour, Annika
    Zellmeier, Evelyn
    Reibke, Roland
    Kolb, Hans-Jochem
    Subklewe, Marion
    Fiegl, Michael
    Hiddemann, Wolfgang
    Spiekermann, Karsten
    Tischer, Johanna
    BLOOD, 2014, 124 (21)
  • [28] Monitoring of minimal residual disease using WT1 assay for patients with chronic myeloid leukemia who undergo allogeneic stem cell transplantation
    H Tamaki
    H Ogawa
    Bone Marrow Transplantation, 2004, 34 : 653 - 654
  • [29] Monitoring of minimal residual disease using WT1 assay for patients with chronic myeloid leukemia who undergo allogeneic stem cell transplantation
    Tamaki, H
    Ogawa, H
    BONE MARROW TRANSPLANTATION, 2004, 34 (07) : 653 - 654
  • [30] Monitoring of minimal residual disease using a quantitative polymerase chain reaction in chronic myeloid leukaemia patients after allogeneic haematopoietic stem cell transplantation
    Gozdzik, J
    Iwola, M
    Lewandowski, K
    Komarnicki, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S325 - S326
12345